Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Payables (2023 - 2025)

Historic Payables for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $626964.0.

  • Mangoceuticals' Payables fell 1138.56% to $626964.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $626964.0, marking a year-over-year decrease of 1138.56%. This contributed to the annual value of $987501.0 for FY2024, which is 60152.45% up from last year.
  • Per Mangoceuticals' latest filing, its Payables stood at $626964.0 for Q3 2025, which was down 1138.56% from $1.3 million recorded in Q2 2025.
  • Mangoceuticals' Payables' 5-year high stood at $1.3 million during Q2 2025, with a 5-year trough of $89059.0 in Q3 2023.
  • Over the past 3 years, Mangoceuticals' median Payables value was $713084.5 (recorded in 2024), while the average stood at $695028.4.
  • Per our database at Business Quant, Mangoceuticals' Payables surged by 69443.85% in 2024 and then crashed by 1138.56% in 2025.
  • Mangoceuticals' Payables (Quarter) stood at $140765.0 in 2023, then skyrocketed by 601.52% to $987501.0 in 2024, then plummeted by 36.51% to $626964.0 in 2025.
  • Its Payables was $626964.0 in Q3 2025, compared to $1.3 million in Q2 2025 and $1.2 million in Q1 2025.